human | Q5 |
P496 | ORCID iD | 0000-0002-6989-1054 |
P735 | given name | Giancarlo | Q3762791 |
Giancarlo | Q3762791 | ||
P106 | occupation | researcher | Q1650915 |
Q57911913 | A functional MRI study of cortical activations associated with object manipulation in patients with MS |
Q91943466 | A new electrophysiological non-invasive method to assess retinocortical conduction time in the Dark Agouti rat through the simultaneous recording of electroretinogram and visual evoked potential |
Q57911812 | A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes |
Q48887791 | A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. |
Q52147661 | Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue. |
Q52152219 | Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis. |
Q57911626 | Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosis |
Q39938023 | Abnormalities of the executive control network in multiple sclerosis phenotypes: An fMRI effective connectivity study. |
Q62652940 | Added value of multimodal MRI to the clinical diagnosis of primary progressive aphasia variants |
Q48621190 | Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. |
Q48846499 | Brain MR Imaging in Patients with Lower Motor Neuron-Predominant Disease. |
Q91012683 | Brain and cord imaging features in neuromyelitis optica spectrum disorders |
Q48321600 | Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy. |
Q48521285 | Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. |
Q48111458 | Brain macro- and microscopic damage in patients with paediatric MS. |
Q51211071 | Brain network connectivity assessed using graph theory in frontotemporal dementia. |
Q37039670 | Brain reserve and cognitive reserve in multiple sclerosis: what you've got and how you use it |
Q53377097 | CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients. |
Q48470442 | Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis. |
Q57911602 | Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability |
Q46515719 | Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study. |
Q40478495 | Clinical deterioration due to co-occurrence of multiple sclerosis and glioblastoma: report of two cases. |
Q90701685 | Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS |
Q47882340 | Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study. |
Q90085582 | Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72 |
Q48806993 | Corpus callosum damage and cognitive dysfunction in benign MS. |
Q57911896 | Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes |
Q88711593 | Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders |
Q35765058 | Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. |
Q43786099 | Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS. |
Q30770517 | Demyelination and cortical reorganization: functional MRI data from a case of subacute combined degeneration. |
Q48270159 | Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations. |
Q92885652 | Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis |
Q34527935 | Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. |
Q86426230 | Erratum to: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting |
Q90803664 | Functional and structural plasticity following action observation training in multiple sclerosis |
Q48151144 | Functional cortical changes of the sensorimotor network are associated with clinical recovery in multiple sclerosis. |
Q48262890 | Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment. |
Q89122520 | Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis |
Q47975209 | Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis. |
Q48074885 | Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression. |
Q88439253 | Hippocampal-related memory network in multiple sclerosis: A structural connectivity analysis |
Q94603683 | Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study |
Q62652950 | Imaging correlates of hand motor performance in multiple sclerosis: A multiparametric structural and functional MRI study |
Q49664670 | Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis |
Q57374095 | Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial |
Q33932577 | Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. |
Q57911803 | Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients? |
Q90943399 | Italian consensus on treatment of spasticity in multiple sclerosis |
Q48009677 | Long-term disability progression in primary progressive multiple sclerosis: a 15-year study |
Q60368969 | Low frequency and rare coding variation contributes to multiple sclerosis risk |
Q38414131 | MRI signatures of the frontotemporal lobar degeneration continuum. |
Q48148715 | MRI substrates of sustained attention system and cognitive impairment in pediatric MS patients. |
Q48316434 | Mapping face encoding using functional MRI in multiple sclerosis across disease phenotypes. |
Q42503511 | Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. |
Q48854909 | Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients. |
Q84228818 | Microbubbles as drug delivery systems in cerebrovascular diseases |
Q43255778 | Motor area localization using fMRI-constrained cortical current density reconstruction of movement-related cortical potentials, a comparison with fMRI and TMS mapping. |
Q37329730 | Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes. |
Q59649446 | Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up |
Q91569840 | Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein |
Q48332271 | Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions--a diffusion tensor MR study. |
Q58551587 | Optic nerve involvement in experimental autoimmune encephalomyelitis to homologous spinal cord homogenate immunization in the dark agouti rat |
Q48711116 | Patterns of white matter diffusivity abnormalities in Leber's hereditary optic neuropathy: a tract-based spatial statistics study. |
Q44116778 | Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors. |
Q57911720 | Posterior brain damage and cognitive impairment in pediatric multiple sclerosis |
Q47185754 | Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study |
Q48580557 | Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. |
Q30384958 | Reading, writing, and reserve: Literacy activities are linked to hippocampal volume and memory in multiple sclerosis. |
Q96953273 | Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study |
Q49052180 | Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. |
Q52151058 | Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis. |
Q98161464 | Repetitive Transcranial Magnetic Stimulation With H-Coil Coupled With Cycling for Improving Lower Limb Motor Function After Stroke: An Exploratory Study |
Q48773126 | Selective decreased grey matter volume of the pain-matrix network in cluster headache. |
Q48451289 | Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease. |
Q34530563 | Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis. |
Q57911808 | Structural and functional MRI correlates of Stroop control in benign MS |
Q44779862 | Structural brain MRI abnormalities in pediatric patients with migraine. |
Q48196944 | Structural brain abnormalities in patients with vestibular migraine. |
Q62652953 | Structural connectivity in multiple sclerosis and modeling of disconnection |
Q48020669 | Structural connectivity-defined thalamic subregions have different functional connectivity abnormalities in multiple sclerosis patients: Implications for clinical correlations |
Q92669171 | Survival prediction models in motor neuron disease |
Q33665968 | Thalamic damage and long-term progression of disability in multiple sclerosis. |
Q43972338 | The "vegetarian brain": chatting with monkeys and pigs? |
Q41475478 | The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis. |
Q36062456 | The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study. |
Q59649437 | The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis |
Q57911888 | The level of spinal cord involvement influences the pattern of movement-associated cortical recruitment in patients with isolated myelitis |
Q57911833 | The mirror-neuron system and handedness: A “right” world? |
Q48646311 | The organization of intrinsic brain activity differs between genders: a resting-state fMRI study in a large cohort of young healthy subjects. |
Q100940353 | The role of B cells in Multiple Sclerosis and related disorders |
Q30810168 | The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis. |
Q102203793 | Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors |
Q42328370 | Treatment Challenges of a Primary Vertebral Artery Aneurysm Causing Recurrent Ischemic Strokes. |
Q48270106 | White matter microstructure abnormalities in pediatric migraine patients. |
Q48651164 | Working memory network dysfunction in relapse-onset multiple sclerosis phenotypes: A clinical-imaging evaluation. |
Search more.